Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting

PL Enright, M Studnicka, J Zielinski - European respiratory …, 2005 - books.google.com
Most people with chronic obstructive pulmonary disease (COPD) are unaware of the
smoldering airway inflammation present in their lungs, which places them at increased risk …

Managing comorbidity in COPD: a difficult task

IG Tsiligianni, E Kosmas, T Van der Molen… - Current drug …, 2013 - ingentaconnect.com
Chronic obstructive pulmonary disease is a public health problem that results in high
morbidity, disability and mortality. Comorbidities are highly prevalent in COPD patients …

Health hazards due to clenbuterol residues in food

TYK Chan - Journal of toxicology: clinical toxicology, 1999 - Taylor & Francis
Excess fat in meat products is considered a major contributory factor to the prevalence of
coronary heart disease in the Westernized societies. In response to the market demand for …

Long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety

A Rossi, S Khirani, M Cazzola - International journal of chronic …, 2008 - Taylor & Francis
COPD is characterized by progressive airflow obstruction which does not fully reverse to
inhaled or oral pharmacotherapy. The management of patients with COPD has taken a …

Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?

BP Yawn, A Kaplan - Primary care respiratory journal, 2008 - nature.com
There has been increased awareness and recognition of COPD in both developed and
developing nations. As people with COPD are identified and treated before they reach end …

[图书][B] Meyler's side effects of cardiovascular drugs

JK Aronson - 2009 - books.google.com
Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect
of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the …

Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long‐term condition: a mixed methods review

EJ Dennett, S Janjua, E Stovold… - Cochrane Database …, 2021 - cochranelibrary.com
Background Chronic obstructive pulmonary disease (COPD) is a chronic respiratory
condition characterised by shortness of breath, cough and recurrent exacerbations. People …

[PDF][PDF] Coexistent chronic obstructive pulmonary disease-heart failure: mechanisms, diagnostic and therapeutic dilemmas

SK Chhabra, M Gupta - Indian J Chest Dis Allied Sci, 2010 - researchgate.net
Mortality in chronic obstructive pulmonary disease (COPD) is more often due to cardiac
rather than respiratory causes. The coexistence of heart failure (HF) and COPD is frequent …

Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects

FL Dini, R Cogo - Current medical research and opinion, 2000 - Taylor & Francis
Summary Doxofylline (7-(1, 3-dioxalan-2-ylmethyl) theophylline) is a novel xanthine
bronchodilator which differs from theophylline in that it contains a dioxalane group in …

Inhaled bronchodilators and the risk of tachyarrhythmias

CH Lee, S Choi, EJ Jang, HM Yang, HI Yoon… - International Journal of …, 2015 - Elsevier
Background/objectives There have been controversies about whether inhaled
bronchodilators could increase the risk of clinically important tachyarrhythmias. We …